Details for New Drug Application (NDA): 091045
✉ Email this page to a colleague
The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.
Summary for 091045
Tradename: | METOPROLOL TARTRATE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | metoprolol tartrate |
Patents: | 0 |
Pharmacology for NDA: 091045
Mechanism of Action | Adrenergic beta-Antagonists |
Suppliers and Packaging for NDA: 091045
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METOPROLOL TARTRATE | metoprolol tartrate | INJECTABLE;INJECTION | 091045 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1365 | 51662-1365-1 | 5 mL in 1 VIAL (51662-1365-1) |
METOPROLOL TARTRATE | metoprolol tartrate | INJECTABLE;INJECTION | 091045 | ANDA | Fresenius Kabi USA, LLC | 63323-660 | 63323-660-05 | 10 VIAL in 1 TRAY (63323-660-05) / 5 mL in 1 VIAL (63323-660-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/ML | ||||
Approval Date: | Oct 25, 2010 | TE: | AP | RLD: | No |
Complete Access Available with Subscription